Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Diagnostic Utility of Cytomegalovirus Nucleic Acid Testing during Antigenemia-Guided Cytomegalovirus Monitoring after Hematopoietic Stem Cell Transplantation or Liver Transplantation.

Morinaga Y, Sawayama Y, Hidaka M, Mori S, Taguchi J, Takatsuki M, Eguchi S, Miyazaki Y, Yanagihara K.

Tohoku J Exp Med. 2019 Mar;247(3):179-187. doi: 10.1620/tjem.247.179.

2.

Evaluation of COBAS AmpliPrep/COBAS TaqMan CMV Test for use in hematopoietic stem cell transplant recipients.

Ramanan P, Razonable RR.

Expert Rev Mol Diagn. 2017 Jul;17(7):633-639. doi: 10.1080/14737159.2017.1325737. Epub 2017 May 15. Review.

PMID:
28468570
3.

CMV antigenemia and quantitative viral load assessments in hematopoietic stem cell transplant recipients.

Cardeñoso L, Pinsky BA, Lautenschlager I, Aslam S, Cobb B, Vilchez RA, Hirsch HH.

J Clin Virol. 2013 Feb;56(2):108-12. doi: 10.1016/j.jcv.2012.10.001. Epub 2012 Nov 10.

PMID:
23146665
4.

Development and evaluation of a quantitative assay detecting cytomegalovirus transcripts for preemptive therapy in allogeneic hematopoietic stem cell transplant recipients.

Ishii K, Onishi Y, Miyamura N, Fukuhara N, Ishizawa K, Nakanishi M, Ohnaka S, Miyasaka T, Kanno E, Kawakami K, Harigae H, Kaku M.

J Med Virol. 2017 Jul;89(7):1265-1273. doi: 10.1002/jmv.24775. Epub 2017 Mar 6.

PMID:
28165158
5.

[Prevalence of human herpesvirus-6 in allogeneic hematopoietic stem cell transplant recipients in correlation with cytomegalovirus infection].

Wang LR, Dong LJ, Lu DP.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2006 Dec;14(6):1204-9. Chinese.

PMID:
17204195
6.

Randomized, placebo-controlled, double-blind study of a cytomegalovirus-specific monoclonal antibody (MSL-109) for prevention of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.

Boeckh M, Bowden RA, Storer B, Chao NJ, Spielberger R, Tierney DK, Gallez-Hawkins G, Cunningham T, Blume KG, Levitt D, Zaia JA.

Biol Blood Marrow Transplant. 2001;7(6):343-51.

7.

Cytomegalovirus diagnosis in renal and bone marrow transplant recipients: the impact of molecular assays.

Halwachs-Baumann G, Wilders-Truschnig M, Enzinger G, Eibl M, Linkesch W, Dornbusch HJ, Santner BI, Marth E, Kessler HH.

J Clin Virol. 2001 Jan;20(1-2):49-57.

PMID:
11163583
8.

Monitoring of human cytomegalovirus infections in heart transplant recipients by pp65 antigenemia.

Sénéchal M, Dorent R, du Montcel ST, Fillet AM, Ghossoub JJ, Dubois M, Pavie A, Gandjbakhch I.

Clin Transplant. 2003 Oct;17(5):423-7.

PMID:
14703924
9.

Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation.

Mori T, Mori S, Kanda Y, Yakushiji K, Mineishi S, Takaue Y, Gondo H, Harada M, Sakamaki H, Yajima T, Iwao Y, Hibi T, Okamoto S.

Bone Marrow Transplant. 2004 Feb;33(4):431-4.

PMID:
14676775
10.

Abstension from treatment of low-level pp65 cytomegalovirus antigenemia after liver transplantation: a prospective study.

Vivarelli M, De Ruvo N, Lazzarotto T, Bellusci R, Landini MP, Varani S, Cavallari A.

Transplantation. 2000 Oct 27;70(8):1183-7.

PMID:
11063338
11.

Combined foscarnet-ganciclovir treatment for cytomegalovirus infections after allogeneic hemopoietic stem cell transplantation.

Bacigalupo A, Bregante S, Tedone E, Isaza A, Van Lint MT, Trespi G, Occhini D, Gualandi F, Lamparelli T, Marmont AM.

Transplantation. 1996 Aug 15;62(3):376-80.

PMID:
8779686
12.

Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients.

Sanghavi SK, Abu-Elmagd K, Keightley MC, St George K, Lewandowski K, Boes SS, Bullotta A, Dare R, Lassak M, Husain S, Kwak EJ, Paterson DL, Rinaldo CR.

J Clin Virol. 2008 Aug;42(4):335-42. doi: 10.1016/j.jcv.2008.03.031. Epub 2008 May 21.

PMID:
18495527
13.

Prevention and treatment of cytomegalovirus infection in organ transplant recipients.

Kusne S, Shapiro R, Fung J.

Transpl Infect Dis. 1999 Sep;1(3):187-203. Review.

PMID:
11428989
14.

Monitoring of cytomegalovirus reactivation after allogeneic stem cell transplantation: comparison of an antigenemia assay and quantitative real-time polymerase chain reaction.

Yakushiji K, Gondo H, Kamezaki K, Shigematsu K, Hayashi S, Kuroiwa M, Taniguchi S, Ohno Y, Takase K, Numata A, Aoki K, Kato K, Nagafuji K, Shimoda K, Okamura T, Kinukawa N, Kasuga N, Sata M, Harada M.

Bone Marrow Transplant. 2002 Apr;29(7):599-606.

15.

Diagnostic yield of the cytomegalovirus (CMV) antigenemia assay and clinical features in solid organ transplant recipients and hematopoietic stem cell transplant recipients with CMV pneumonia.

Moon SM, Sung H, Kim MN, Lee SO, Choi SH, Kim YS, Woo JH, Kim SH.

Transpl Infect Dis. 2012 Apr;14(2):192-7. doi: 10.1111/j.1399-3062.2011.00703.x. Epub 2012 Jan 20.

PMID:
22260384
16.

Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan.

Kanda Y, Mineishi S, Saito T, Seo S, Saito A, Suenaga K, Ohnishi M, Niiya H, Nakai K, Takeuchi T, Kawahigashi N, Shoji N, Ogasawara T, Tanosaki R, Kobayashi Y, Tobinai K, Kami M, Mori S, Suzuki R, Kunitoh H, Takaue Y.

Bone Marrow Transplant. 2001 Feb;27(4):437-44.

17.

[Comparison of the CMV antigenemia test and CMV-DNA PCR results in solid organ transplant recipients].

Özkarata E, Özbek ÖA, Avkan Oğuz V, Sayıner AA.

Mikrobiyol Bul. 2016 Jan;50(1):44-52. Turkish. Erratum in: Mikrobiyol Bul. 2016 Apr;50(2):352. Özkarataş, Emre [corrected to Özkarata, Emre].

18.

The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation.

Webb BJ, Harrington R, Schwartz J, Kammerer J, Spalding J, Lee E, Dodds B, Kaufusi S, Goodman BE, Firth SD, Martin G, Sorensen J, Hoda D.

Transpl Infect Dis. 2018 Oct;20(5):e12961. doi: 10.1111/tid.12961. Epub 2018 Jul 20.

PMID:
29975816
19.

Comparison of quantitative cytomegalovirus real-time PCR in whole blood and pp65 antigenemia assay: clinical utility of CMV real-time PCR in hematopoietic stem cell transplant recipients.

Choi SM, Lee DG, Lim J, Park SH, Choi JH, Yoo JH, Lee JW, Kim Y, Han K, Min WS, Shin WS, Kim CC.

J Korean Med Sci. 2009 Aug;24(4):571-8. doi: 10.3346/jkms.2009.24.4.571. Epub 2009 Jul 29.

20.

[Detection of Cytomegalovirus Antigenemia Guides Prophylaxis of Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation]

Fan W, Li YH, Dong LJ, Pian HY, Lu SJ.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2001 Jun;9(2):149-152. Chinese.

PMID:
12578623

Supplemental Content

Support Center